Tackling uncertainties for rare diseases - The use of RWE to improve access for patients

Friday, 5 October 2018 | 12.00-13.30 | Kursaal C

Organised by Shire

View photo collection

Read the conference report

New innovations require fresh tools and policy approaches to ensure we can adequately and equitably meet the needs of those with rare diseases. This is particularly true given their small patient populations and lack of data which can lead to late or no access. The potential of real world evidence must be exploited to address uncertainties that occur during the evidence generation pathways. The TRUST-4RD multi-stakeholder initiative has created a practical tool to address evidentiary requirements and the use of RWE to enable earlier patient access.

This session will:

  • Examine how RWE can be used to address current levels of insufficient data so that regulators, HTA bodies, payers and society can better assess the value of treatments for complex or rare conditions.
  • Discuss what is missing and look into how evidence generation can help meet the unmet needs of patients.
  • Discuss how health data can be used to ensure a patient centric approach to the management and treatment of people with complex or rare conditions.
  • Give context to the debate on access and sustainability of healthcare systems at European and national level.
  • Share best practice from the European Reference Networks and explore the use of data and knowledge for treating patients in EU Member States.

Views and insights from academia, the ERNs, national/European policy-makers, patient representatives and industry will be shared during the workshop. The panel will be followed by Q&A with the audience.

Session Recording

Session Recording

Speakers & panellists

Input from

SIMONE BOSELLI, Public Affairs Director, EURORDIS

LIISA-MARIA VOIPIO-PULKKI, Head of the Management Support Unit, Ministry of Social Affairs and Health, Finland

HEIDRUN IRSCHIK-HADJIEFF, Vice President DACH Cluster, Shire

RUTH LADENSTEIN, Professor of Paediatrics, Head of the Clinical Trials Unit S²IRP - CCRI (Studies & Statistics for Integrated Research and Projects) St. Anna Kinderkrebsforschung e.V.


VINCIANE PIRARD, Task-force Member, Senior Public Affairs Director, SANOFI Genzyme

MAURIZIO SCARPA, Past Chairman of the ERN Coordinator Group, European Reference Networks


JOHN BOWIS, Special Adviser to FIPRA, Former MEP and Member of the UK Parliament

Available Biographical Information

NameBoselli, Simone
CVDownload PDF
NameVoipio-Pulkki, Liisa-Maria
CVDownload PDF
NameIrschik-Hadjieff, Heidrun
CVDownload PDF
NameNatz, Alexander
CVDownload PDF
NamePirard, Vinciane
CVDownload PDF
PresentationDownload PDF
NameLadenstein, Ruth
CVDownload PDF
NameScarpa, Maurizio
CVDownload PDF
NameBowis, John
CVDownload PDF


EHFG News & Updates

EHFG Headquarters

EHFG Vienna Office

VAT No. ATU44155007 Bank Data:
IBAN AT 152040400200222240 
Bank Salzburger Sparkasse
Kurgartenstraße, 5630 Bad Hofgastein, Austria